Asset Allocation

As of November 30, 2025.
Type % Net
Cash 0.10%
Stock 49.23%
Bond 40.72%
Convertible 0.51%
Preferred 6.85%
Other 2.59%
View Asset Allocation
Start Trial

Market Capitalization

As of November 30, 2025
Large 52.06%
Mid 14.62%
Small 33.32%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 92.14%    % Emerging Markets: 3.01%    % Unidentified Markets: 4.85%

Americas 90.60%
84.58%
Canada 8.20%
United States 76.38%
6.02%
Brazil 2.99%
As of November 30, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 4.54%
United Kingdom 1.73%
2.81%
France 0.88%
Germany 0.00%
Ireland 0.01%
Italy 0.00%
Netherlands 0.00%
Switzerland 0.24%
0.00%
0.00%
Greater Asia 0.01%
Japan 0.00%
0.00%
0.01%
South Korea 0.00%
Taiwan 0.01%
0.00%
Unidentified Region 4.85%

Bond Credit Quality Exposure

AAA 0.00%
AA 43.55%
A 0.64%
BBB 0.98%
BB 14.55%
B 11.67%
Below B 3.09%
    CCC 2.96%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.13%
Not Rated 0.00%
Not Available 25.52%
Short Term 0.00%
As of November 30, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
20.32%
Materials
1.66%
Consumer Discretionary
11.64%
Financials
5.96%
Real Estate
1.06%
Sensitive
54.64%
Communication Services
6.52%
Energy
18.52%
Industrials
8.36%
Information Technology
21.24%
Defensive
21.74%
Consumer Staples
1.95%
Health Care
9.85%
Utilities
9.94%
Not Classified
3.30%
Non Classified Equity
0.25%
Not Classified - Non Equity
3.05%
As of November 30, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of November 30, 2025
Type % Net
Government 50.97%
Corporate 27.10%
Securitized 1.12%
Municipal 0.00%
Other 20.81%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
0.76%
Less than 1 Year
0.76%
Intermediate
53.24%
1 to 3 Years
13.23%
3 to 5 Years
27.03%
5 to 10 Years
12.98%
Long Term
45.06%
10 to 20 Years
1.05%
20 to 30 Years
43.90%
Over 30 Years
0.11%
Other
0.93%
As of November 30, 2025
View Bond Maturity Exposure
Start Trial